Bupivacaine Hydrochloride Injection


0.25% 5 mL single-dose ampules (NDC 59923-717-05)

0.25% 10 mL single-dose ampules (NDC 59923-719-10)

0.5% 5 mL single-dose ampules (NDC 59923-718-05)

0.5% 10 mL single-dose ampules (NDC 59923-720-10)

Availability and Estimated Shortage Duration


Related Information

Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage. Importation will begin mid-September 2019. Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers. Please call Areva Pharmaceutical Customer Service at 812-399-3599, Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.
Dear Health Care Provider Letter

Shortage Reason (per FDASIA)


US FDA Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=c&tab=tabs-1